Acquisition of Audentes Therapeutics by Astellas

Astellas Pharma acquired Audentes Therapeutics for $3 billion.

Is a

Acquired Company

Acquirer

Acquisition Amount (USD)

3,000,000,000

Date Announced

December 3, 2019

Transaction Date Closed

January 16, 2020

No article content yet.

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like Acquisition of Audentes Therapeutics by Astellas

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.